Procalcitonin as an Alternative Tumor Marker of Medullary Thyroid Carcinoma.
Luca M GiovanellaMaria Luisa GaroLuca CerianiGaetano PaoneAlfredo Campenni'Federica D'AurizioPublished in: The Journal of clinical endocrinology and metabolism (2021)
The high accuracy, compounded with favorable analytical characteristics, give ProCT great potential to replace calcitonin as a new standard of care in the management of MTC.